Grace Therapeutics, Inc. (GRCE) — Capital Reinvestment Ratio
Latest as of December 2012:
0.59x
Grace Therapeutics, Inc. (GRCE) has a Capital Reinvestment Ratio of 0.59x as of December 2012, meaning it reinvests 1% of its operating cash flow ($136.29K) in capital expenditures ($80.55K). Check tangible equity quality of Grace Therapeutics, Inc. to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.59x
Capex / Operating Cash Flow
Operating Cash Flow
$136.29K
USD
Capital Expenditures
$80.55K
USD
Data as of
Dec 2012
Most recent filing
Annual Capital Reinvestment Ratio for Grace Therapeutics, Inc. (None–None)
Year-by-year Capital Reinvestment Ratio for Grace Therapeutics, Inc. from None to None. See Grace Therapeutics, Inc. (GRCE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow